Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-07-18FDA Approved: CLONAZEPAM — Supplemental Application (Solco Healthcare LLC)
The FDA approved a supplemental application for clonazepam submitted by Solco Healthcare LLC.
-
FDA approval · 2016-07-18FDA Approved: ZONISAMIDE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Zonisamide from BluePoint Laboratories.
-
FDA approval · 2016-07-18FDA Approved: CLONAZEPAM — Supplemental Application (Advagen Pharma Ltd)
The FDA approved a supplemental application for clonazepam submitted by Advagen Pharma Ltd.
-
FDA approval · 2016-07-18FDA Approved: ZONISAMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a supplemental application for zonisamide submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2016-06-24FDA Approved: DIAZEPAM — Original Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved the original application for diazepam oral from Chartwell Governmental & Specialty RX, LLC. This marks approval of a generic di…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-06-17FDA Approved: LAMOTRIGINE — Original Application (Dr. Reddys Laboratories Inc.)
The FDA approved the original application for a generic Lamotrigine product from Dr. Reddys Laboratories Inc.
-
FDA approval · 2016-06-16FDA Approved: DILANTIN-125 — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DILANTIN-125 (phenytoin) submitted by Viatris Specialty LLC.
-
FDA approval · 2016-06-16FDA Approved: CEREBYX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Cerebyx (fosphenytoin sodium) submitted by Pfizer Laboratories Div Pfizer Inc, expanding the…
-
FDA approval · 2016-06-13FDA Approved: KLONOPIN — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for Klonopin (clonazepam) from H2-Pharma, LLC. The action updates labeling as part of the supple…
-
FDA approval · 2016-06-03FDA Approved: BRIVIACT — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for Briviact (brivaracetam) submitted by UCB, Inc.
-
FDA approval · 2016-06-03FDA Approved: BRIVIACT — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for Briviact (brivaracetam) submitted by UCB, Inc.
-
FDA approval · 2016-06-03FDA Approved: BRIVIACT — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for Briviact (brivaracetam) submitted by UCB, Inc.
-
FDA approval · 2016-05-23FDA Approved: PENTOBARBITAL SODIUM — Original Application (Sagent Pharmaceuticals)
The FDA approved an Original Application (ANDA) for pentobarbital sodium from Sagent Pharmaceuticals, establishing a generic version of this…
-
FDA approval · 2016-05-16FDA Approved: FOSPHENYTOIN — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for fosphenytoin sodium from Fresenius Kabi USA, LLC under an existing ANDA.
-
FDA approval · 2016-05-12FDA Approved: DEPAKOTE ER — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Depakote ER (divalproex sodium) submitted by AbbVie.
-
FDA approval · 2016-04-29FDA Approved: FYCOMPA — Original Application (Eisai Inc.)
The FDA granted original approval for FYCOMPA (perampanel) from Eisai Inc. for add-on therapy in patients with partial-onset seizures, marki…
-
FDA approval · 2016-03-14FDA Approved: GABAPENTIN — Original Application (Ajenat Pharmaceuticals LLC)
FDA approves a new generic gabapentin product (Original Application) by Ajenat Pharmaceuticals LLC under anANDA; the approval covers the sam…
-
FDA approval · 2016-03-03FDA Approved: CEREBYX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Cerebyx (fosphenytoin sodium) submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2016-02-26FDA Approved: ZONISAMIDE — Supplemental Application (Exelan Pharmaceuticals, Inc.)
FDA approved a supplemental application for zonisamide (Exelan Pharmaceuticals) under ANDA077869. This action relates to the approved generi…
-
FDA approval · 2016-02-26FDA Approved: VIMPAT — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for VIMPAT (lacosamide) from UCB, Inc., expanding/adjusting its approved labeling for the drug.
-
FDA approval · 2016-02-19FDA Approved: MYSOLINE — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for Mysoline (primidone) submitted by Bausch Health US, LLC.
-
FDA approval · 2016-02-18FDA Approved: BRIVIACT — Original Application (UCB, Inc.)
FDA approved Briviact (brivaracetam) based on UCB, Inc.'s original NDA, establishing it as an adjunctive therapy for partial-onset seizures …
-
FDA approval · 2016-02-18FDA Approved: BRIVIACT — Original Application (UCB, Inc.)
The FDA approved Briviact (brivaracetam) as an adjunctive treatment for partial-onset seizures in adults and in children aged 4 years and ol…
-
FDA approval · 2016-02-18FDA Approved: BRIVIACT — Original Application (UCB, Inc.)
FDA approved Briviact (brivaracetam) under its original application by UCB, Inc. for adjunctive treatment of partial-onset seizures in epile…
-
FDA approval · 2016-02-18FDA Approved: DEPAKOTE ER — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Depakote ER (divalproex sodium) from AbbVie Inc., granting an additional regulatory authorizatio…